» Articles » PMID: 37973653

Proposal for a New Morphological "combined Type" of Gallbladder Cancer: Description of Radiopathological Characteristics and Comparison with Other Morphological Types

Abstract

Objective: To describe the radiopathological characteristics of a new morphological "combined type" of gallbladder cancer (GBC) and compare it with the mass replacing gallbladder and thickening types of GBC.

Materials And Methods: The imaging and pathological details of consecutive patients with GBC between August 2020 and December 2022 were retrospectively reviewed. Two radiologists reviewed computed tomography/magnetic resonance imaging in consensus for the morphological type of GBC. The radiologists classified GBC as mass replacing gallbladder, wall thickening, and combined type. The combined type was defined as a mass arising from the thickened wall of an adequately distended gallbladder that extended exophytically into the adjacent liver parenchyma. The presence of calculi, site, and size of lesion, biliary/portal vein involvement, liver, lymph node, and omental metastases was compared among the various types. The pathological characteristics were also compared.

Results: Of the 481 patients (median age 55 years, 63.2% females) included in the study, mass replacing gallbladder, wall thickening, and combined-type GBC were seen in 42.8% (206/481), 40.5% (195/481), and 16.6% (80/481) of patients, respectively. In the combined type of GBC, biliary/portal vein involvement was seen in 63.7% (51/80) and 7.5% (6/80) of patients. Liver, lymph node, and omental metastases were seen in 67.5% (54/80), 40% (32/80), and 41.2% (33/80) patients, respectively. Liver metastases were significantly more common in the combined type (p = 0.002). There were no significant differences in pathological characteristics among the various types.

Conclusion: Combined-type GBC is less common than the mass replacing gallbladder and thickening types and is associated with a higher risk of liver metastases.

Citing Articles

Enhancement Patterns of Malignant Gallbladder Masses at Multiphasic Contrast-enhanced CT: Associations With Clinicoradiopathological Features.

Kalage D, Sajjana G, Hegde S, Gulati A, Yadav T, Kaman L J Clin Exp Hepatol. 2024; 14(6):102377.

PMID: 39183738 PMC: 11342763. DOI: 10.1016/j.jceh.2024.102377.


Gallbladder cancer: Progress in the Indian subcontinent.

Kumar A, Sarangi Y, Gupta A, Sharma A World J Clin Oncol. 2024; 15(6):695-716.

PMID: 38946839 PMC: 11212610. DOI: 10.5306/wjco.v15.i6.695.


Editorial: Role of imaging in biliary tract cancer: diagnosis, staging, response prediction and image-guided therapeutics.

Gupta P, Kambadakone A, Sirohi B Front Oncol. 2024; 14:1387531.

PMID: 38567157 PMC: 10985351. DOI: 10.3389/fonc.2024.1387531.

References
1.
Hundal R, Shaffer E . Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014; 6:99-109. PMC: 3952897. DOI: 10.2147/CLEP.S37357. View

2.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

3.
Vendrami C, Magnetta M, Mittal P, Moreno C, Miller F . Gallbladder Carcinoma and Its Differential Diagnosis at MRI: What Radiologists Should Know. Radiographics. 2020; 41(1):78-95. DOI: 10.1148/rg.2021200087. View

4.
Levy A, Murakata L, Rohrmann Jr C . Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics. 2001; 21(2):295-314; questionnaire, 549-55. DOI: 10.1148/radiographics.21.2.g01mr16295. View

5.
Gupta P, Kumar M, Sharma V, Dutta U, Sandhu M . Evaluation of gallbladder wall thickening: a multimodality imaging approach. Expert Rev Gastroenterol Hepatol. 2020; 14(6):463-473. DOI: 10.1080/17474124.2020.1760840. View